CU20090039A7 - 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE - Google Patents

4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE

Info

Publication number
CU20090039A7
CU20090039A7 CU20090039A CU20090039A CU20090039A7 CU 20090039 A7 CU20090039 A7 CU 20090039A7 CU 20090039 A CU20090039 A CU 20090039A CU 20090039 A CU20090039 A CU 20090039A CU 20090039 A7 CU20090039 A7 CU 20090039A7
Authority
CU
Cuba
Prior art keywords
fluorophenoxy
phenyl
amino
carboxamide
monohidrate
Prior art date
Application number
CU20090039A
Other languages
Spanish (es)
Inventor
Birgit Keil
Katharina Tenbieg
Brigit Keil
Juergen Stiehl
Alfons Grunenberg
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Priority to CU20090039A priority Critical patent/CU20090039A7/en
Publication of CU20090039A7 publication Critical patent/CU20090039A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invención se refiere a 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-N-metilpiridina-2-carboxamida monohidrato, a procedimientos para su preparación, a composiciones farmacéuticas que lo comprenden y a su uso en el combate de trastornos.The present invention relates to 4- [4 - ({[4-chloro-3- (trifluoromethyl) phenyl] carbamoyl} amino) -3-fluorophenoxy] -N-methylpyridine-2-carboxamide monohydrate, to processes for its preparation, to pharmaceutical compositions that comprise it and its use in the combat of disorders.

CU20090039A 2009-03-13 2009-03-13 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE CU20090039A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20090039A CU20090039A7 (en) 2009-03-13 2009-03-13 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20090039A CU20090039A7 (en) 2009-03-13 2009-03-13 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE

Publications (1)

Publication Number Publication Date
CU20090039A7 true CU20090039A7 (en) 2011-10-14

Family

ID=45000050

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090039A CU20090039A7 (en) 2009-03-13 2009-03-13 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE

Country Status (1)

Country Link
CU (1) CU20090039A7 (en)

Similar Documents

Publication Publication Date Title
CR10663A (en) 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE
UY30319A1 (en) DPP IV INHIBITORS FORMULATIONS
NI201500142A (en) 3-ACETYLAMINO-1 (PHENYL-HETEROARIL-AMINOCARBONIL OR PHENYL-HETEROARYL-CARBONYLAMINE) DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
BR112014010177A2 (en) compound, pharmaceutical composition, use of the compound, and method for the prophylaxis or treatment of a disease state or condition
BRPI0820665A2 (en) peptidyl nitrile compounds, processes for their manufacture, pharmaceutical composition, combination and use of said compounds
CU20070068A7 (en) THERMODYNAMICALLY STABLE FORM OF A TOSILATE SALT
BR112014014558A8 (en) pharmaceutical composition, use of a crth2 antagonist and a proton pump inhibitor, and kit for the treatment of eosinophilic esophagitis
CL2009001484A1 (en) Glycinate salt of metformin; pharmaceutical composition comprising the salt; and its use to treat hyperglycemia.
BRPI1013984A2 (en) compound, pharmaceutical composition, method for treating or prophylaxis of a disease or condition, and use of a compound.
CL2007003100A1 (en) COMPOUNDS DERIVED FROM PIRIMIDINA, INHIBITORS OF CISTEINE PROTEASA; PREPARATION PROCESSES; SALES OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF MALARIA.
BRPI1009781A2 (en) compounds for the treatment of metabolic disorders, pharmaceutical compositions comprising them and their use
BRPI0914371A2 (en) "compound, pharmaceutical composition, use of a compound, method of treating an individual, and combination product"
BR112014005025A2 (en) pharmaceutical composition for use in the treatment of a neurodegenerative disease
UY34008A (en) ? FORMS IN SOLID STATE OF HIV INHIBITOR, PHARMACEUTICAL COMPOSITION, USE OF THE SAME, AND PROCESSES TO PREPARE SUCH FORMS ?.
MX368900B (en) COMPOSITION BASED ON AMINO ACIDS FOR THE RECOVERY OF FIBROELASTIN IN DERMAL CONNECTIVE TISSUES.
UY33530A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY AND INFLAMMATORY DISEASES
BR112013024824A2 (en) Isopentyl esters for use in cosmetic, dermatological or pharmaceutical compositions
ES2641849T3 (en) Oxadiazole compound and procedure for its preparation, pharmaceutical composition and its use
BR112012020629A2 (en) crystalline form and method for the therapy of a disorder
ES2415029A8 (en) Pharmaceutical composition and use of an antibody to prepare a medicament intended to inhibit the production or amplify the elimination of the P24 protein.
BRPI0914323A2 (en) compound, pharmaceutical formulation, use of a compound, and methods for treating a condition and treating and preventing disorders
BR112012029824A2 (en) methods for the preparation of glycopyrronium chloride, glycopyrronium chloride, pharmaceutical composition and use of glycopyrronium chloride
ECSP10010711A (en) 7-SULFANILMETIL-, 7-SULFINILMETIL- AND 7-SULFONILMETILINDOLES REPLACED AND THE USE OF THE SAME
CL2014000595A1 (en) Cynara extract; pharmaceutical composition that contains it; and its use for the treatment of hyperglycemia, hypercholesterolemia, hypertension and hepatic steatosis.
CU20090039A7 (en) 4- [4 - ({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] CARBAMOIL} AMINO) -3-FLUOROPHENOXY] -N-METHYL-PYRIDINE-2-CARBOXAMIDE MONOHIDRATE